TY - JOUR AU - Prior, T. W. AU - Snyder, P. J. AU - Rink, B. D. AU - Pearl, D. K. AU - Pyatt, R. E. AU - Mihal, D. C. PY - 2010 DA - 2010// TI - Newborn and carrier screening for spinal muscular atrophy JO - Am J Med Genet Part A VL - 152 UR - https://doi.org/10.1002/ajmg.a.33474 DO - 10.1002/ajmg.a.33474 ID - Prior2010 ER - TY - JOUR AU - Sugarman, E. A. AU - Nagan, N. AU - Zhu, H. AU - Akmaev, V. R. AU - Zhou, Z. AU - Rohlfs, E. M. PY - 2012 DA - 2012// TI - Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens JO - Eur J Hum Genet VL - 20 UR - https://doi.org/10.1038/ejhg.2011.134 DO - 10.1038/ejhg.2011.134 ID - Sugarman2012 ER - TY - JOUR AU - Pearn, J. PY - 1978 DA - 1978// TI - Incidence, prevalence, and gene frequency studies of chronic childhood muscular atrophy JO - J Med Genet VL - 15 UR - https://doi.org/10.1136/jmg.15.6.409 DO - 10.1136/jmg.15.6.409 ID - Pearn1978 ER - TY - JOUR AU - Ogino, S. AU - Wilson, R. B. AU - Gold, B. PY - 2004 DA - 2004// TI - New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations JO - Eur J Hum Genet VL - 12 UR - https://doi.org/10.1038/sj.ejhg.5201288 DO - 10.1038/sj.ejhg.5201288 ID - Ogino2004 ER - TY - JOUR AU - Arnold, W. D. AU - Kassar, D. AU - Kissel, J. T. PY - 2015 DA - 2015// TI - Spinal muscular atrophy: diagnosis and management in a new therapeutic era JO - Muscle Nerve VL - 51 UR - https://doi.org/10.1002/mus.24497 DO - 10.1002/mus.24497 ID - Arnold2015 ER - TY - JOUR AU - Kayadjanian, N. AU - Burghes, A. AU - Finkel, R. S. AU - Mercuri, E. AU - Rouault, F. AU - Schwersenz, I. PY - 2013 DA - 2013// TI - SMA-EUROPE workshop report: opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe JO - Orphanet J Rare Dis VL - 8 UR - https://doi.org/10.1186/1750-1172-8-44 DO - 10.1186/1750-1172-8-44 ID - Kayadjanian2013 ER - TY - JOUR AU - Wang, C. H. AU - Finkel, R. S. AU - Bertini, E. S. AU - Schroth, M. AU - Simonds, A. AU - Wong, B. PY - 2007 DA - 2007// TI - Consensus statement for standard of care in spinal muscular atrophy JO - J Child Neurol VL - 22 UR - https://doi.org/10.1177/0883073807305788 DO - 10.1177/0883073807305788 ID - Wang2007 ER - TY - JOUR AU - Kaufmann, P. AU - McDermott, M. P. AU - Darras, B. T. AU - Finkel, R. AU - Kang, P. AU - Oskoui, M. PY - 2011 DA - 2011// TI - Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year JO - Arch Neurol VL - 68 UR - https://doi.org/10.1001/archneurol.2010.373 DO - 10.1001/archneurol.2010.373 ID - Kaufmann2011 ER - TY - JOUR AU - Meldrum, C. AU - Scott, C. AU - Swoboda, K. J. PY - 2007 DA - 2007// TI - Spinal muscular atrophy genetic counseling access and genetic knowledge: parents’ perspectives JO - J Child Neurol VL - 22 UR - https://doi.org/10.1177/0883073807305672 DO - 10.1177/0883073807305672 ID - Meldrum2007 ER - TY - JOUR AU - Markowitz, J. PY - 2012 DA - 2012// TI - A., Singh P, Darras BT. Spinal muscular atrophy: a clinical and research update JO - Pediatr Neurol VL - 46 UR - https://doi.org/10.1016/j.pediatrneurol.2011.09.001 DO - 10.1016/j.pediatrneurol.2011.09.001 ID - Markowitz2012 ER - TY - JOUR AU - Nurputra, D. K. AU - Lai, P. S. AU - Harahap, N. I. F. AU - Morikawa, S. AU - Yamamoto, T. AU - Nishimura, N. PY - 2013 DA - 2013// TI - Spinal muscular atrophy: from gene discovery to clinical trials JO - Ann Hum Genet VL - 77 UR - https://doi.org/10.1111/ahg.12031 DO - 10.1111/ahg.12031 ID - Nurputra2013 ER - TY - JOUR AU - Zanetta, C. AU - Nizzardo, M. AU - Simone, C. AU - Monguzzi, E. AU - Bresolin, N. AU - Comi, G. P. PY - 2014 DA - 2014// TI - Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials JO - Clin Ther VL - 36 UR - https://doi.org/10.1016/j.clinthera.2013.11.006 DO - 10.1016/j.clinthera.2013.11.006 ID - Zanetta2014 ER - TY - STD TI - Waldman R, Bosboom W, van den Berg L, Wokke J, Iannaccone S, Vrancken A. Drug treatment for spinal muscular atrophy types II and III. Cochrane Database Syst Rev. 2011;(4):CD006282. doi:10.1002/14651858.CD006282.pub4. ID - ref13 ER - TY - JOUR AU - Kaufmann, P. AU - McDermott, M. P. AU - Darras, B. T. AU - Finkel, R. S. AU - Sproule, D. M. AU - Kang, P. B. PY - 2012 DA - 2012// TI - Prospective cohort study of spinal muscular atrophy types 2 and 3 JO - Neurology VL - 79 UR - https://doi.org/10.1212/WNL.0b013e318271f7e4 DO - 10.1212/WNL.0b013e318271f7e4 ID - Kaufmann2012 ER - TY - JOUR AU - Kirschner, J. AU - Schorling, D. AU - Hauschke, D. AU - Rensing-Zimmermann, C. AU - Wein, U. AU - Grieben, U. PY - 2014 DA - 2014// TI - Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study JO - Neuromuscul Disord VL - 24 UR - https://doi.org/10.1016/j.nmd.2013.10.011 DO - 10.1016/j.nmd.2013.10.011 ID - Kirschner2014 ER - TY - JOUR AU - Chen, T. PY - 2010 DA - 2010// TI - Randomized, double-blind, placebo-controlled trial of Hydroxyurea in spinal muscular atrophy JO - Neurology VL - 75 UR - https://doi.org/10.1212/WNL.0b013e3182020332 DO - 10.1212/WNL.0b013e3182020332 ID - Chen2010 ER - TY - JOUR AU - Mercuri, E. AU - Bertini, E. AU - Muntoni, F. PY - 2003 DA - 2003// TI - The Hammersmith motor functional scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation JO - Eur J Paediatr Neurol VL - 7 UR - https://doi.org/10.1016/S1090-3798(03)00060-6 DO - 10.1016/S1090-3798(03)00060-6 ID - Mercuri2003 ER - TY - JOUR AU - O’Hagen, J. AU - Glanzman, A. M. AU - M.P. PY - 2007 DA - 2007// TI - M. An expanded version of the Hammersmith functional motor scale for SMA II and III patients JO - Neuromuscul Disord VL - 17 UR - https://doi.org/10.1016/j.nmd.2007.05.009 DO - 10.1016/j.nmd.2007.05.009 ID - O’Hagen2007 ER - TY - JOUR AU - Glanzman, A. M. AU - JM, O. ’. H. AU - MP, M. D. AU - Martens, W. B. PY - 2011 DA - 2011// TI - Validation of the expanded Hammersmith functional motor scale in spinal muscular atrophy type II and III JO - J Child Neurol VL - 26 UR - https://doi.org/10.1177/0883073811420294 DO - 10.1177/0883073811420294 ID - Glanzman2011 ER - TY - JOUR AU - Montes, J. AU - Glanzman, A. M. AU - Mazzone, E. S. AU - Martens, W. B. AU - Dunaway, S. AU - Pasternak, A. PY - 2015 DA - 2015// TI - SMA functional composite score: a functional measure in spinal muscular atrophy JO - Muscle and Nerve VL - 52 UR - https://doi.org/10.1002/mus.24670 DO - 10.1002/mus.24670 ID - Montes2015 ER - TY - JOUR AU - Sivo, S. AU - Mazzone, E. AU - Antonaci, L. AU - De Sanctis, R. AU - Fanelli, L. AU - Palermo, C. PY - 2015 DA - 2015// TI - Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes JO - Neuromuscul Disord VL - 25 UR - https://doi.org/10.1016/j.nmd.2014.11.008 DO - 10.1016/j.nmd.2014.11.008 ID - Sivo2015 ER - TY - STD TI - Seferian AM, Moraux A, Canal A, Decostre V, Diebate O, Le Moing AG, et al. Upper Limb Evaluation and One-Year Follow Up of Non-Ambulant Patients with Spinal Muscular Atrophy: An Observational Multicenter Trial. PLoS One 2015;10. doi:10.1371/journal.pone.0121799. ID - ref22 ER - TY - STD TI - Mazzone E, Bianco F, Martinelli D, Glanzman AM, Messina S, Sanctis R De, et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord 2011;21:406–412. doi:10.1016/j.nmd.2011.02.014. ID - ref23 ER - TY - JOUR AU - Peay, H. AU - Hollin, I. AU - Fischer, R. AU - Bridges, J. F. P. PY - 2014 DA - 2014// TI - A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for duchenne muscular distrophy JO - Clin Ther VL - 36 UR - https://doi.org/10.1016/j.clinthera.2014.04.011 DO - 10.1016/j.clinthera.2014.04.011 ID - Peay2014 ER - TY - JOUR AU - Crosby, R. D. AU - Kolotkin, R. L. AU - Williams, G. R. PY - 2003 DA - 2003// TI - Defining clinically meaningful change in health-related quality of life JO - J Clin Epidemiol VL - 56 UR - https://doi.org/10.1016/S0895-4356(03)00044-1 DO - 10.1016/S0895-4356(03)00044-1 ID - Crosby2003 ER - TY - STD TI - FDA HHS. Guidance for industry use in medical product development to support labeling claims guidance for industry. Clin Fed Regist. 2009:1–39. ID - ref26 ER - TY - JOUR AU - McLeod, L. D. AU - Coon, C. D. AU - Martin, S. A. AU - Fehnel, S. E. AU - Hays, R. D. PY - 2011 DA - 2011// TI - Interpreting patient-reported outcome results: US FDA guidance and emerging methods JO - Expert Rev Pharmacoecon Outcomes Res VL - 11 UR - https://doi.org/10.1586/erp.11.12 DO - 10.1586/erp.11.12 ID - McLeod2011 ER - TY - STD TI - Qian Y, McGraw S, Henne J, Jarecki J, Hobby K, Yeh W. Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study n.d. ID - ref28 ER - TY - JOUR AU - Main, M. PY - 2003 DA - 2003// TI - The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation JO - Eur J Paediatr Neurol VL - 7 UR - https://doi.org/10.1016/S1090-3798(03)00060-6 DO - 10.1016/S1090-3798(03)00060-6 ID - Main2003 ER - TY - BOOK AU - Glaser, B. AU - Strauss, A. PY - 1967 DA - 1967// TI - The discovery of grounded theory: strategies for qualitative research PB - Aldine Publishing Company CY - Chicago ID - Glaser1967 ER - TY - JOUR AU - Bradley, E. H. AU - Curry, L. A. AU - Devers, K. J. PY - 2007 DA - 2007// TI - Qualitative data analysis for health services research: developing taxonomy, themes, and theory JO - J Heal Serv Res VL - 42 UR - https://doi.org/10.1111/j.1475-6773.2006.00684.x DO - 10.1111/j.1475-6773.2006.00684.x ID - Bradley2007 ER - TY - STD TI - Dedoose: 6.1.11 n.d. dedoose.com. Accessed 2 Apr 2017. UR - http://dedoose.com ID - ref32 ER - TY - JOUR AU - Pera, M. C. AU - Coratti, G. AU - Forcina, N. AU - Mazzone, E. S. AU - Scoto, M. AU - Montes, J. PY - 2017 DA - 2017// TI - Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy JO - BMC Neurol VL - 17 UR - https://doi.org/10.1186/s12883-017-0790-9 DO - 10.1186/s12883-017-0790-9 ID - Pera2017 ER - TY - JOUR AU - Rouault, F. AU - Christie-Brown, V. AU - Broekgaarden, R. AU - Gusset, N. AU - Henderson, D. AU - Marczuk, P. PY - 2017 DA - 2017// TI - Disease impact on general well-being and therapeutic expectations of European type II and type III spinal muscular atrophy patients JO - Neuromuscul Disord ID - Rouault2017 ER - TY - JOUR AU - Iannaccone, S. T. AU - Hynan, L. S. AU - Morton, A. AU - Buchanan, R. AU - Limbers, C. A. AU - Varni, J. W. PY - 2009 DA - 2009// TI - The PedsQL in pediatric patients with spinal muscular atrophy: feasibility, reliability, and validity of the pediatric quality of life inventory generic Core scales and neuromuscular module JO - Neuromuscul Disord VL - 19 UR - https://doi.org/10.1016/j.nmd.2009.09.009 DO - 10.1016/j.nmd.2009.09.009 ID - Iannaccone2009 ER -